Lipid-lowering therapy in the older adults: are we asking the right questions?
-
By
-
Amal Aïdoud
-
September 25, 2025
-
0 min
By
Amal Aïdoud
September 25, 2025
by Amal Aïdoud
September 25, 2025
The Allurion Gastric Balloon System is now authorized by the US Food and Drug Administration for short-term weight loss in adults aged 22 to 65 years with obesity and a body mass index of 30 to 40 kg/m2.
February 23, 2026
A VHA study across 11 vendors finds AI-generated primary care notes score lower than clinician-written notes, with the largest deficits in thoroughness, organization, and usefulness
by Kerri Miller
April 17, 2026